CUMULATIVE SAFETY ASSESSMENT OF THE TAKEDA TETRAVALENT DENGUE VACCINE CANDIDATE IN PARTICIPANTS 4 TO 60 YEARS OLD

被引：0
|
作者：
Patel, Sanjay S. [1 ]
Rauscher, Martina [1 ]
Peng, Hang [2 ]
机构：
[1] Takeda Pharmaceut, Zurich, Switzerland
[2] Takeda Pharmaceut Int Inc, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 105卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1290
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [21] 3 years of post-licensure safety data on a live attenuated tetravalent dengue vaccine (CYD-TDV)
    Rojas, Andrey
    Haney, Owen
    Marcelon, Lydie
    Khromava, Alena
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 390 - 391
  • [22] Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Esquilin-Rivera, Ines
    Oh, Helen M. L.
    Raanan, Marsha
    Sariol, Carlos A.
    Shek, Lynette P.
    Simasathien, Sriluck
    Smith, Mary Kathryn
    Dario Velez, Ivan
    Wallace, Derek
    Gordon, Gilad S.
    Stinchcomb, Dan T.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10): : 1562 - 1572
  • [23] INTEGRATED IMMUNOGENICITY ANALYSIS OF A TETRAVALENT DENGUE VACCINE (CYD-TDV) UP TO 4 YEARS AFTER VACCINATION
    Vigne, Claire
    Dupuy, Martin
    Richetin-Guilluy, Aline
    Guy, Bruno
    Jackson, Nicholas
    Bonaparte, Matthew
    Hu, Branda
    Saville, Melanie
    Chansinghakul, Danaya
    Noriega, Fernando
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 434 - 434
  • [24] Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice
    Aggarwal, Charu
    Ramasamy, Viswanathan
    Garg, Amit
    Shukla, Rahul
    Khanna, Navin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Rivera, Ines Esquilin
    Kilbury, Jennifer
    Raanan, Marsha
    Borkowski, Astrid
    Papadimitriou, Athanasia
    Wallace, Derek
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (09): : 1513 - 1520
  • [26] PERSISTENCE OF NEUTRALIZING ANTIBODIES ONE YEAR AFTER TWO DOSES OF A CANDIDATE RECOMBINANT TETRAVALENT DENGUE VACCINE IN SUBJECTS AGED FROM 1.5 TO 45 YEARS
    Wallace, Derek
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 373 - 373
  • [27] Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial
    Tricou, Vianney
    Saez-Llorens, Xavier
    Yu, Delia
    Rivera, Luis
    Jimeno, Jose
    Villarreal, Ana Cecilia
    Dato, Epiphany
    de Suman, Onix Saldana
    Montenegro, Nathali
    DeAntonio, Rodrigo
    Mazara, Sonia
    Vargas, Maria
    Mendoza, Debbie
    Rauscher, Martina
    Brose, Manja
    Lefevre, Inge
    Tuboi, Suely
    Borkowski, Astrid
    Wallace, Derek
    LANCET, 2020, 395 (10234): : 1434 - 1443
  • [28] Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
    George, Sarah L.
    Wong, Mimi A.
    Dube, Tina J. T.
    Boroughs, Karen L.
    Stovall, Janae L.
    Luy, Betty E.
    Haller, Aurelia A.
    Osorio, Jorge E.
    Eggemeyer, Linda M.
    Irby-Moore, Sharon
    Frey, Sharon E.
    Huang, Claire Y. -H.
    Stinchcomb, Dan T.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (07): : 1032 - 1041
  • [29] Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study
    Tricou, Vianney
    Essink, Brandon
    Ervin, John E.
    Turner, Mark
    Escudero, Ian
    Rauscher, Martina
    Brose, Manja
    Lefevre, Inge
    Borkowski, Astrid
    Wallace, Derek
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (03):
  • [30] Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru A Randomized Trial
    Lopez, Pio
    Lanata, Claudio F.
    Zambrano, Betzana
    Cortes, Margarita
    Andrade, Teresa
    Amemiya, Isabel
    Terrones, Cynthia
    Gil, Ana I.
    Verastegui, Hector
    Marquez, Viviana
    Crevat, Denis
    Jezorwski, John
    Noriega, Fernando
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (10) : 1140 - 1147
12345